Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heterozygous protein C deficiency type I.

B Kemkes-Matthes1

  • 1Zentrum für Innere Medizin, Justus Liebig Universität Giessen, Federal Republic of Germany.

Blut
|April 1, 1989
PubMed
Summary

Heterozygous protein C deficiency, a risk factor for blood clots, rarely causes complications, especially in children. Oral anticoagulants are not recommended unless complications arise, to avoid risks like skin necrosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Prehospital management of acute coronary syndrome in patients on long-term direct oral anticoagulant treatment].

Der Anaesthesist·2019
Same author

[Anticoagulation-direct oral anticoagulants].

Der Internist·2017
Same author

Hämostaseologie--Progress in Haemostasis. GTH is moving to a European scientific society.

Hamostaseologie·2016
Same author

Reduced platelet aggregation in a boy with scurvy.

Klinische Padiatrie·2012
Same author

[Hemorrhagic disorders].

Der Internist·2012
Same author

Inhibitor-immunology-study. Evaluation of inhibitor development in haemophilia B.

Hamostaseologie·2011

Area of Science:

  • Biochemistry
  • Hematology
  • Genetics

Background:

  • Protein C is a vitamin K-dependent plasma protein with anticoagulatory and profibrinolytic functions.
  • Heterozygous protein C deficiency is a known risk factor for thromboembolic diseases.
  • The study investigates a family with protein C deficiency to assess clinical manifestations.

Observation:

  • A family of 16 members exhibited protein C deficiency.
  • Only two individuals within the family presented with thromboembolic disorders.
  • Thromboembolic complications were rare in childhood and not obligatory in adulthood among affected members.

Findings:

  • Heterozygous protein C deficiency does not invariably lead to thromboembolic complications.
  • Oral anticoagulants are not advised for asymptomatic protein C deficient patients.
  • Coumarin therapy poses a risk of skin necrosis in protein C deficient individuals.

Implications:

  • Clinical management of protein C deficiency requires careful risk assessment.
  • Avoidance of prophylactic oral anticoagulation in asymptomatic patients is recommended.
  • Initiating coumarin therapy with low doses and heparin overlap can mitigate risks in protein C deficient patients.

Related Experiment Videos